Loading...
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
IMPORTANCE: Moving to multigene testing for all women with breast cancer (BC) could identify many more mutation carriers who can benefit from precision prevention. However, the cost-effectiveness of this approach remains unaddressed. OBJECTIVE: To estimate incremental lifetime effects, costs, and co...
Na minha lista:
| Udgivet i: | JAMA Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Medical Association
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6777250/ https://ncbi.nlm.nih.gov/pubmed/31580391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.3323 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|